Summerton J, Weller D
ANTIVIRALS Inc., Corvallis, OR 97333, USA.
Antisense Nucleic Acid Drug Dev. 1997 Jun;7(3):187-95. doi: 10.1089/oli.1.1997.7.187.
Antisense promised major advances in treating a broad range of intractable diseases, but in recent years progress has been stymied by technical problems, most notably inadequate specificity, ineffective delivery into the proper subcellular compartment, and unpredictable activity within cells. Herein is an overview of the design, preparation, and properties of Morpholino oligos, a novel antisense structural type that solves the sequence specificity problem and provides high and predictable activity in cells. Morpholino oligos also exhibit little or no nonantisense activity, afford good water solubility, are immune to nucleases, and are designed to have low production costs.
反义技术曾有望在治疗多种难治性疾病方面取得重大进展,但近年来,其进展因技术问题而受阻,最显著的是特异性不足、无法有效递送至合适的亚细胞区室以及细胞内活性不可预测。本文概述了吗啉代寡核苷酸的设计、制备及其特性,吗啉代寡核苷酸是一种新型反义结构类型,解决了序列特异性问题,并在细胞中具有高效且可预测的活性。吗啉代寡核苷酸还几乎没有非反义活性,具有良好的水溶性,对核酸酶免疫,并且设计成生产成本较低。